 | | PRD_000183 | | Name: | Microcin C7 | | Formula: | C28 H49 N12 O10 S | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_002489 | | Name: | lipid II mimetic, LPATA: Thr-in conformation | | Formula: | C53 H85 N14 O16 | | Definition date: | 2022-09-07 | | Last modified: | 2023-11-03 |
|
 | | PRD_000198 | | Name: | BETA LICHENICIDIN PREPEPTIDE | | Formula: | C133 H200 N36 O37 S4 | | Description: | LICHENICIDIN VK21 IS A TETRACYCLIC PEPTIDE. POST TRANSLATIONAL
MATURATION OF LANTIBIOTICS INVOLVES THE ENZYMIC CONVERSION OF THR, AND
SER INTO DEHYDRATED AMINO ACIDS AND THE FORMATION OF THIOETHER BONDS
WITH CYSTEINE. THIOETHER BONDS WITH CYSTEINE RESULT IN FOUR RINGS.
THIS IS FOLLOWED BY MEMBRANE TRANSLOCATION AND CLEAVAGE OF THE
MODIFIED PRECURSOR. | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_002510 | | Name: | Minihepcidin PR73 | | Formula: | C86 H136 N21 O15 S | | Definition date: | 2022-12-07 | | Last modified: | 2023-11-03 |
|
 | | PRD_000213 | | Name: | motuporin | | Formula: | C40 H57 N5 O10 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000224 | | Name: | Polytheonamide B | | Formula: | C219 H376 N60 O72 S | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_001041 | | Name: | TMC-95A mimic ligand yCP:4e | | Formula: | C61 H83 N9 O10 | | Definition date: | 2013-05-01 | | Last modified: | 2023-11-03 |
|
 | | PRD_001044 | | Name: | TMC-95A mimic ligand yCP:3a | | Formula: | C60 H80 N8 O11 | | Definition date: | 2013-05-01 | | Last modified: | 2023-11-03 |
|
 | | PRD_001047 | | Name: | (2E,4E)-N-[(2R,3S)-1-{[(5S,8S,9E)-2,7-dioxo-5-(propan-2-yl)-1,6-diazacyclododec-9-en-8-yl]amino}-3-hydroxy-1-oxobutan-2-yl]dodeca-2,4-dienamide | | Formula: | C29 H48 N4 O5 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_001049 | | Name: | TMC-95A mimic ligand yCP:4a chain Q | | Formula: | C55 H72 N8 O9 | | Definition date: | 2013-05-01 | | Last modified: | 2023-11-03 |
|
 | | PRD_001066 | | Name: | Muramyl tetrapeptide | | Formula: | C30 H53 N8 O13 | | Definition date: | 2014-03-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_001069 | | Name: | N-acetyl-L-alanyl-L-alanyl-N-[(2S)-1-hydroxypropan-2-yl]-L-prolinamide | | Formula: | C16 H28 N4 O5 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000292 | | Name: | BETA-SECRETASE INHIBITOR NVP-AMK640 | | Formula: | C29 H50 N6 O10 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_001075 | | Name: | N-[(2S)-3-(3-tert-butyl-1,2,4-oxadiazol-5-yl)-1-({(2S)-1-[(4-methylbenzyl)amino]-1-oxo-4-phenylbutan-2-yl}amino)-1-oxopropan-2-yl]-5-methyl-1,2-oxazole-3-carboxamide | | Formula: | C32 H38 N6 O5 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000330 | | Name: | (5S,8R,11S)-8-(2-carboxyethyl)-5-(carboxymethyl)-14-(4-ethoxy-4-oxobutanoyl)-11-(1-methylethyl)-3,6,9,12-tetraoxo-1-phenyl-2-oxa-4,7,10,13,14-pentaazahexadecan-16-oic acid | | Formula: | C30 H41 N5 O14 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000332 | | Name: | Cbz-Asp-Glu-Val-AAsp-CHCH-CON(CH3)CH2Ph | | Formula: | C36 H46 N6 O13 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_001125 | | Name: | Peptide ligand | | Formula: | C51 H75 N9 O14 | | Definition date: | 2013-12-04 | | Last modified: | 2023-11-03 |
|
 | | PRD_001157 | | Name: | Ser-Leu-Phe-His-Phenylalanyl-reduced-peptide-bond-Tyrosyl-Thr-Pro | | Formula: | C51 H69 N10 O11 | | Definition date: | 2014-01-15 | | Last modified: | 2023-11-03 |
|
 | | PRD_000387 | | Name: | N-(tert-butoxycarbonyl)-L-alanyl-L-alanyl-N-{(1R)-1-[(S)-[(1S)-2-{[(1R)-1-carboxyethyl]amino}-1-methyl-2-oxoethoxy](hydroxy)phosphoryl]-2-methylpropyl}-L-prolinamide | | Formula: | C26 H46 N5 O11 P | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000395 | | Name: | ACE-HAC-ARG-MAA-HAQ-SEL | | Formula: | C37 H58 N9 O8 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_001184 | | Name: | Dimethyl FK228 | | Formula: | C26 H42 N4 O6 S2 | | Description: | DIMETHYL FK228 IS THE REDUCED AND MODIFIED FORM OF ROMIDEPSIN. THE DISULFIDE INTRAMOLECULAR LINKAGE OF ROMIDEPSIN IS BROKEN, AND BOTH SULFHYDRYL GROUPS ARE METHYLATED. | | Definition date: | 2014-03-05 | | Last modified: | 2023-11-03 |
|
 | | PRD_001189 | | Name: | ATSP-7041 stapled-peptide | | Formula: | C87 H124 N16 O22 | | Definition date: | 2013-11-20 | | Last modified: | 2023-11-03 |
|
 | | PRD_001198 | | Name: |
(3aR,5aS,8S,10aS)-1-[(3S,6R,8aS)-1'-[(2S)-2-acetamido-3-(2-chlorophenyl)propanoyl]-5-oxidanylidene-spiro[1,2,3,8a-tetrahydroindolizine-6,2'-pyrrolidine]-3-yl]carbonyl-10-oxidanylidene-2,3,3a,5a,8,10a-hexahydrodipyrrolo[3,2-b:3',1'-f]azepine-8-carboxylic acid | | Formula: | C35 H38 Cl N5 O7 | | Definition date: | 2014-10-15 | | Last modified: | 2023-11-03 |
|
 | | PRD_001215 | | Name: | Macrocyclic Inhibitor (3R,6S,9S,12E,16S)-9-(3-AMINO-3-OXO-PROPYL)-3-[(4-BENZOYLPHENYL)METHYL]-6-(CYCLOHEXYLMETHYL)-2,5,8,11,14-PENTAOXO-1,4,7,10,15-PENTAZACYCLOICOS-12-ENE-16-CARBOXAMIDE | | Formula: | C40 H48 N7 O9 | | Definition date: | 2014-05-21 | | Last modified: | 2023-11-03 |
|
 | | PRD_000456 | | Formula: | C39 H67 N12 O10 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
